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Abstract
Background: Rapid placement of a reliable airway is the most important task in anesthesia practice. Airway management is a
critical skill to provide safe anesthesia since morbidity. In addition, mortality due to anesthesia could be linked to difficulty or
failure in airway management. In this study, intubation success was compared between two methods, AirQ-ILA and LMAfastrach,
among candidates for elective surgery under general anesthesia.
Methods: In this clinical trial, patients, who were candidates for elective surgery under general anesthesia at Firoozgar and Rasoul
Akram Hospitals, were randomly divided into LMAfastrach and AirQ-ILA groups. Heart rate before and after induction and intu-
bation, diastolic blood pressure, systolic blood pressure, duration of device insertion, intubation time, number of attempts until
successful device insertion and trachea intubation, and success or failure in the insertion of the device and the tube were recorded;
as for statistical analysis, SPSS version 21 was considered.
Results: In comparison with the LMAfastrach group, the device insertion time and intubation time were significantly longer in the
AirQ-ILA group (P < 0.05). However, the groups showed no significant difference regarding the number of device and tube insertion
attempts (P > 0.05). Moreover, no significant difference was observed in the success of device insertion and intubation in either
LMAfastrach or AirQ-ILA group (P >0.05).
Conclusions: The LMAfastrach and AirQ-ILA methods were not significantly different regarding the success of airway instrument
application and intubation, while the device insertion time and intubation time were significantly longer in the AirQ-ILA group in
comparison with the LMAfastrach group.
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1. Background
General anesthesia has several effects on the respira-
tory system, the most important of which is the reduction
of airway reflex mechanism, laxity of muscle pharynx and
larynx, hypoventilation, and apnea (1). Airway manage-
ment in patients undergoing general anesthesia is a set of
actions that result in the creation of a safe and secure air-
way for ventilation (2). Failure in the airway management
and hypoxia can lead to irreversible brain damage within
only a few minutes. Therefore, establishing a fast and se-
cure airway is one of the most important tasks of an anes-
thesiologist.
Morbidity and mortality due to anesthesia might be
attributed to difficulty or failure in airway management
(3). The safest and most effective method to establish the
airway is the use of direct laryngoscopy and tracheal tube
placement (4). Since 1880, when the use of airway intu-
bation was firstly simulated, several methods and devices
have been introduced. As a matter of fact, direct laryn-
goscopy and tracheal intubation remain the gold standard
(5). Depending on the circumstances, intubation with di-
rect laryngoscopy may sometimes fail and it also may be
dangerous for anesthesiologists; therefore, the use of new
alternative tools is always considered.
The main reason for failure in laryngoscopy is the
anatomical condition of the patient and the physician’s ex-
perience in performing a laryngoscopy (6). The availability
of alternative equipment and methods may increase the
success rate for anesthesiologists. Some alternative facili-
ties are used to ease airway management with less manip-
ulation. All of these devices are placed at the top of the
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glottis. In fact, they are fixed in the pharynx, which is an-
other auxiliary airway management method not requiring
a laryngoscope (7). However, devices such as the LMA (la-
ryngeal mask airway), Igel (8) and combitube could be very
helpful for patient ventilation. However, endotracheal in-
tubation is a better way to prevent aspiration of the gastric
contents, and in some cases, it has restrictions with posi-
tive pressure ventilation (9). The replacement devices of
laryngoscopy for the tracheal tube include lighted stylet
and c-trach (10). Additionally, some other devices are used,
and their usefulness has been confirmed in ventilation of
patients. The benefits of this tool include the following:
ease of placement, no special skills needed, and general in-
tubation of the trachea (11).
The intubating LMA or LMA Fastrach was designed
specifically to facilitate tracheal intubation during main-
taining ventilation (12). The ILMA overcomes the diameter-
length limitations for the tracheal tube imposed by classic
LMA and facilitates guidance of the tracheal tube towards
the glottis (2). Nonetheless, the ILMA method comes with
some limitations, it requires the use of expensive (high
pressure cuffed, reinforced) silicone and it may not be used
for the pediatric population under 30 kilogram (13).
A newer device similar to Fastrach was recently de-
signed with the name of Air-Q. It is also named as Intubat-
ing Laryngeal Airway. Some facilities have been considered
in the design of this device, such as the epiglottis elevator,
to ease intubation with an endotracheal tube, breathing
tube is shorter and wider than ILMA, and use of inexpen-
sive tracheal tube PVC (Polyvinyl chloride) (14, 15).
The efficacy and success of the new tool have been stud-
ied and compared with other devices of the airway man-
agement. Due to its ease of use, speed of implantation,
and success rate, the aim is to compare AirQ-ILA (AirQ- in-
tubating laryngeal mask) (Cookgas LLC., St. Louis, MO) and
LMAfastrach (Laryngeal Mask Company, Jersey, UK) meth-
ods in patients undergoing elective surgery during general
anesthesia to evaluate whether it is an acceptable alterna-
tive for airway management.
2. Methods
This single-blinded clinical trial was approved by
the Ethical Committee of Iran University of Medical Sci-
ences (IR.IUMS.REC1394.9211174014) and registered in Ira-
nian Clinical Trial site (IRCT20151107024909N7). This study
was conducted in Firoozgar and Rasoul Akram Hospitals
affiliated to the Iran University of Medical Sciences. After
complete explanation to the patients and obtaining writ-
ten consent, patients candidate to surgeries under general
anesthesia were classified randomly into 2 groups using
even and odd numbers (AirQ-ILA and LMAfastrach, respec-
tively).
The inclusion criteria were as follows: fasting for at
least 8 hours, age range of 18 - 60 years, ASA I and II, elective
surgeries within a predicted duration of less than three
hours, and airway profile (thyromental distance (TMD) of
more than 6 cm, mouth opening of more than two finger
widths, and Modified Mallampati classification (15) of I, II,
and III).
The exclusion criteria were as follows: body mass in-
dex (BMI) above 30 kg/m2, diagnosis of gastroesophageal
reflux disease (GERD), and a modified Mallampati classifi-
cation of V. Peripheral oxygen saturation (SpO2), electro-
cardiography (ECG), heart rate (HR), mean arterial pres-
sure (MAP), diastolic blood pressure (DBP), systolic blood
pressure (SBP), and end-tidal CO2 were also monitored. HR
and BP were recorded. Afterwards, anesthesia was induced
according to the following method. Acccording to Jagan-
nathan et al. (15) study and power = 90% and confident in-
terval = 0.05; sample size was calculated and equal to 63 in
each group.
Upon arrival at the operating room, patients’ airway
class were assessed according to modified Mallampati clas-
sification (16) and recorded. All the patients received
5 mg/kg of crystalloid solution and were preoxygenated
with 100% oxygen for 3 minutes. Then, they were premed-
icated with 0.02 mg/kg of midadzolam and 2 µg/kg of fen-
tanyl. Thiopental and atracurium (0.5 mg/kg of each) were
used to induce general anesthesia. After the ‘patients were
ventilated for 3 minutes, the patients’ head were placed in
neutral position and the devices (Air Q-ILA or LMAfastrach)
were applied. For insertion of ILMA, the device was inserted
by one-handed rotational movement in the sagittal plane.
The deflated cuff was lubricated with 2% lidocaine jelly ap-
plied to the posterior surface of the mask bowl and was
flattened against the palate with its rim facing posterioirly.
ILMA was inserted in a circular movement by holding the
handle, while maintaining contact against the curve of the
palate and posterior pharynx. Then, the handle was re-
leased and the cuff was inflated. To obtain the optimal po-
sition for tracheal intubation, the handle was moved side
to side, in and out, or even lifted anteriorly to reach opti-
mised ventilation.
For patients assigned to the Air-Q group, the posterior
surface of the device was lubricated with 2% lidocaine jelly.
The tongue was pushed downwards using a tongue depres-
sor. With the right hand of the operator, the device was in-
serted touching the palate and was gently pushed forward,
until it was stopped with a resistance, then, the cuff was
inflated with the volume recommended by the manufac-
turer. An assistant lifted the patient’s mandibule during
passage of the device to the phrynx. If the air-Q device got
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Table 1. LMAfastrach Size Relative to Body Weight and Endotracheal Tube Size Ac-
cording to the LMAfastrach Size
LMAfastrach Size Patient’s Weight, kg Endotracheal Tube Size, ID
3 30 - 50 7
4 50 - 70 7.5
5 70 - 100 > 7.5
Abbreviation: ID, internal diameter (millimeter).
Table 2. AirQ-ILA Size According to the Patient’s Weight and Endotracheal Tube Size
According to AirQ-ILA
AirQ-ILA Size Patient’s Weight, kg Endotracheal Tube Size, ID
3.5 50 - 70 7 - 7.5
4.5 70 - 100 8 - 8.5
stuck during insertion, the left index finger of the opera-
tor was placed behind the mask to push it forward along
the curve of palate and posterior pharyngeal wall.
The cuff inflated with air as per manufacture’s recom-
mendation.
After confirming proper device insertion through ob-
serving end-tidal CO2 increase and bilateral chest rise on
capnography, the trachea was intubated (disposable rein-
forced PVC in Air-Q group and reinforced silicon tube in
ILMA group). The tracheal tube size was selected according
to the device’s size (Tables 1 and 2).
The tracheal tube was cuffed after intubation. The cor-
rect position of the endotracheal tube was ensured using
capnography and auscultation of breath sounds. If failure
occurred at the first attempt of device insertion, the de-
vice was removed and inserted again. If tracheal intuba-
tion was not successful, the tracheal tube was removed by
keeping the device in place, and tracheal intubation was
then attempted again. After removing the device, intuba-
tion was carried out via direct laryngoscopy if either de-
vice insertion or tracheal intubation was unsuccessful de-
spite three attempts. The number of patients with a suc-
cessful device insertion attempt was recorded and used
for subsequent analysis. The interval between the time
the device passed through the mouth opening and venti-
lation without air leakage (airway pressure, 20 cm H2O)
was interpreted as the device insertion time, while the
interval between intubation with the endotracheal tube
through the device and confirmation of successful intu-
bation was interpreted as intubation time; both intervals
were recorded. Moreover, the number of tracheal intuba-
tion attempts was recorded.
Neostigmine and atropine (0.04 and 0.02 mg/kg, re-
spectively) were used to reverse the neuromuscular block-
ade; after extubation, the patient’s throat was checked for
bleeding. The patient was kept for at least half an hour
in the recovery room. After complete consciousness was
achieved, the patient was asked about complications, in-
cluding sore throat and hoarseness, and the answer was
recorded. All of the above mentioned procedures were
accomplished by one person (named the executive of the
project). Before starting the project, the executive of the
project practiced with the device as well as the tube place-
ment at least 30 times to gain the needed skills.
The gathered data were analyzed by SPSS version 22.
First, the normality of the quantitative variables was as-
sessed based on a Kolmogorov-Smirnov test and was not
confirmed. Therefore, to compare quantitative variables,
Mann-Whitney U test or Independent t-test was applied,
while to compare qualitative variables, Chi square or
Fisher’s exact test was used. The significance level was set
at 0.05.
For sample size calculation, a pilot study comparing
the difference in time duration of device insertion with 10
patients in each group was performed. Based on the results
of the pilot study, the time difference in the duration of de-
vice insertion between the two groups was three minutes
(17± 5 minutes in LMAfastrach group versus 20± 6 min-
utes in AirQ-ILA group. With the consideration of 95% con-
fidence interval and 80% power, the number of patients in
each group was calculated by 53. Due to the probability of
attrition and non-response, 63 patients were assigned to
(in) each group.
3. Results
In this study, 126 eligible patients undergoing elective
surgery were enrolled (Figure 1), and 63 (50%) patients were
assigned to each group (LMAfastrach and AirQ-ILA groups).
Table 3 presents the demographic information. No sig-
nificant differences were found regarding gender, weight,
or age between the LMAfastrach and AirQ-ILA groups (P >
0.05) (Table 3).
The LMAfastrach and AirQ-ILA groups were not signifi-
cantly different in terms of DBP, SBP, MAP, or HR after induc-
tion (P > 0.05). In addition, the LMAfastrach and AirQ-ILA
groups were not significantly different regarding SBP, DBP,
MAP, and HR after intubation (P >0.05). However, a signifi-
cant increase was reported in SBP, DBP, MAP, and HR after in-
duction and intubation in both the LMAfastrach (P < 0.05)
and AirQ-ILA (P < 0.05) groups (Table 4).
In the AirQ-ILA group, the intubation time and device
insertion time were significantly longer than the LMAfas-
trach group (P < 0.05). However, the groups were not sig-
nificantly different considering the number of device and
tube insertion attempts (P > 0.05). Moreover, the groups
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Table 3. Demographic Data in the LMAfastrach and AirQ-ILA Groupsa
Variable Group Total P Value
AirQ-ILA LMAfastrach
Age, y 36± 13.88 39.73± 15.28 37.86± 14.66 0.146
Sex,male 37 (58.7) 34 (54) 71 (56.3) 0.72
Weight, kg 73.95± 12.54 75.28± 15.1 74.61± 13.84 0.924
aValues are expressed as mean± SD or frequency (%).
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Figure 1. Consort flow chart of the study
were not significantly different regarding success in device
and tube insertion (P > 0.05) (Table 5).
There was no significant difference regarding compli-
cations, including sore throat, hoarseness, and bleeding
between the LMAfastrach and AirQ-ILA groups (P > 0.05)
(Table 6).
No significant relationship was observed between the
success of device insertion and Mallampati score of pa-
tients in the LMAfastrach and AirQ-ILA groups (P > 0.05)
(Table 7).
Successful intubation through the device and Mallam-
pati were not significantly associated in the LMAfastrach
and AirQ-ILA groups (P > 0.05) (Table 8).
No significant difference was detected in successful
tube insertion through the device (intubation) in patients
with a Mallampati of 3 in the LMAfastrach and AirQ-ILA
groups (P > 0.05) (Table 9).
4. Discussion
Based on the present findings, the LMAfastrach and
AirQ-ILA groups were not significantly different regarding
the duration of attempts to place the airway device and tra-
cheal tube properly. Additionally, no significant difference
was found in the success of device insertion and intuba-
tion with the device between patients undergoing elective
surgery in the groups. However, the duration of the time
to insert the instrument and tube in AirQ-ILA group was
longer than that of the LMAfastrach group.
In the study of Malhotra et al. which showed simi-
lar results to our study, the authors concluded that the
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Table 4. Comparison of DBP, SBP, MAP, and HR Among Candidates for Elective Surgery in the LMAfastrach and AirQ-ILA Groupsa
Variable Group P1 Value
AirQ-ILA LMAfastrach
SBP,mmHg
Before induction 115.04± 21 117.92± 15.43 0.171
After intubation 122.2± 21.84 122.25± 14.1 0.828
P2 value < 0.001 0.009
DBP,mmHg
Before induction 74.25± 12.61 76.57± 10.61 0.171
After intubation 81.93± 11.65 79.3± 9.8 0.828
P2 value < 0.001 0.035
MAP
Before induction 101.44± 17.67 104.13± 12.89 0.093
After intubation 108.78± 17.74 107.93± 12.2 0.756
P2 value < 0.001 0.007
HR
Before induction 77.01± 13.87 78.3± 14.77 0.397
After intubation 84.03± 10.99 84.55± 10.54 0.785
P2 value < 0.001 < 0.001
aValues are expressed as mean± SD.
Table 5. Comparison of Device and Tube Insertion in Patients Undergoing Elective Surgery in the LMAfastrach and AirQ-ILA Groupsa
Variable Group P Value
AirQ-ILA LMAfastrach
Time insertion of device, s 21.92± 5.4 17.92± 5.94 < 0.001
Time insertion of tube, s 23.92± 7.08 17.93± 4.4 < 0.001
Number of insertion attempts to device 0.201
One 56 (88.9) 61 (96.8)
Two 6 (9.5) 2 (3.2)
Three 1 (1.6) 0 (0)
Number of insertion attempts to tube 0.708
One 51 (92.7) 57 (95)
Two 7 (7.3) 3 (5)
Insertion of device 1
Success 63 (100) 63 (100)
Failure 0 (0) 0 (0)
Insertion of tube 0.205
Success 60 (95.2) 55 (87.3)
Failure 3 (4.8) 8 (12.7)
aValues are expressed as mean± SD or No. (%).
success rate for insertion of the tube in patients undergo-
ing elective surgery after three attempts for the AirQ-ILA
and LMAfastrach methods was 96% and 91%, respectively,
with no meaningful difference. Additionally, the LMAfas-
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Table 6. Comparison of Complications in the LMAfastrach and AirQ-ILA Groupsa
Complication Group P Value
AirQ-ILA LMAfastrach
Sore throat 21 (33.3) 14 (22.2) 0.232
Hoarseness 2 (3.2) 1 (1.6) 1
Bleeding 21 (33.3) 15 (23.8) 0.324
aValues are expressed as frequency (%).
Table 7. Relationship Between the Success of Device Insertion and Mallampati in the
LMAfastrach and AirQ-ILA Groupsa
Group Mallampati Insertion of Device P Value
Success Failure
AirQ-ILA 1
1 16 (100) 0 (0)
2 33 (100) 0 (0)
3 14 (100) 0 (0)
LMAfastrach 1
1 16 (100) 0 (0)
2 35 (100) 0 (0)
3 12 (100) 0 (0)
aValues are expressed as frequency (%).
Table 8. Relationship Between the Successful Intubation Through the Device and
Mallampati in Patients Undergoing Elective Surgery in the LMAfastrach and AirQ-ILA
Groupsa
Group Mallampati Intubation Through the Device P Value
Success Failure
AirQ-ILA 0.578
1 16 (100) 0 (0)
2 31 (88.5) 2 (11.5)
3 13 (92.8) 1 (7.2)
LMAfastrach 0.132
1 16 (100) 0 (0)
2 30 (85.7) 5 (14.3)
3 9 (75) 3 (25)
aValues are expressed as frequency (%).
trach and AirQ-ILA groups were not significantly different
regarding the number of attempts to place the device and
tracheal tube properly. However, unlike the present study,
the time to successfully insert the device and intubate the
trachea through the device was shorter in the AirQ-ILA
group in comparison with the LMAfastrach group (17). In a
similar study, Shamaa et al. reported that the success rates
of inserting the tube in patients under elective surgery af-
Table 9. Comparison of Successful tube Insertion in Patients Undergoing Elective
Surgery with Mallampati Score of 3 in the LMAfastrach and AirQ-ILA Groupsa
Insertion of Tube Group P Value
AirQ-ILA LMAfastrach
Success 9 (75) 13 (92.8)
0.306
Failure 3 (25) 1 (7.22)
aValues are expressed as No. (%).
ter two attempts in the AirQ-ILA and LMA fastrach meth-
ods were 83% and 89%, respectively, with no meaningful
difference. The difference between the attempts to prop-
erly place the airway instrument and intubation was not
significant for the LMAfastrach and AirQ-ILA groups. Ad-
ditionally, the duration of the time to correctly place the
instrument and tracheal tube was longer in the AirQ-ILA
method than in the ILMA fastrach method (18). In consis-
tence with our study, Garzon Sanchez et al. (19) showed that
both LMAfastrach and AirQ-ILA methods have similar suc-
cess rates for applying the tracheal tube.
Badawi et al. showed results consistent with our study
and noticed that the success rates for intubation in pa-
tients under elective surgery after two attempts in the
AirQ-ILA and LMAfastrach methods were 94% and 96%, re-
spectively, and had no meaningful difference. Addition-
ally, the application times of the instrument in the AirQ-
ILA group was greater than that of the LMA fastrach group.
However, the time to successfully intubate the patients was
shorter in the AirQ-ILA group, compared to the LMA fas-
trach group (20). In a study by Abdel-Halim et al. which
showed consistent results with our study, no significant
difference was observed in the time of applying the air-
way instrument in the LMA fastrach and AirQ-ILA groups.
Additionally, the success rate for applying the tube equals
100% after two attempts in both groups. However, unlike
in our study, the application time of the instrument and
tube in the AirQ-ILA group was less than that of the LMAfas-
trach group (21). In the study of Neoh and Choy in which
the results were consistent with our study, they concluded
that there was no difference between the success rate for
applying the airway instrument in patients under elective
surgery for the LMAfastrach and AirQILA groups. However,
unlike in our study, the rate of success for applying the tra-
cheal tube in patients undergoing elective surgery in the
LMAfastrach method was higher than that of the AirQ-ILA
method (22).
In the study of Erlacher et al. the success rates for apply-
ing the tracheal tube by CobraPLUS, AirQ, and LMA fastrach
were 47%, 57%, and 95%, respectively, and as in our study,
they observed that after three attempts, the success rate
for applying the tracheal tube in every three instruments
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was 100% (23). According to a study by Karim and Swan-
son which was consistent with our study, the duration of
intubation in patients undergoing elective surgery in the
AirQ-ILA method was longer than that of the LMAfastrach
method. The success rates for applying the tube after three
attempts in the AirQ-ILA and LMAfastrach methods were
100% and 95%, respectively. Hence, in the results that were
inconsistent with our study, they concluded that the dura-
tion of applying the instrument for patients undergoing
elective surgery in the method of AirQ-ILA was shorter than
that of the LMAfastrach method (13).
Consistent with our study, Sastre et al. (24) showed no
significant difference in intubation success between the
LMAfastrach and AirQ-ILA methods in candidates for elec-
tive surgery. Similarly, in a study by Kim et al. the suc-
cess of applying the tracheal tube in mannequin simula-
tion in the AirQ-ILA method was lower than the LMAfas-
trach method. However, unlike in our study, the duration
for applying the tracheal tube under mannequin simula-
tion in the AirQ-ILA group was less than that of the LMAfas-
trach group (25).
In the study of Attarde et al. they noticed that the suc-
cess rates for applying tubes with the size of 3.5 and 4.5 in
the AirQ-ILA group were 80% and 67%, respectively. They
recommended that the size of the AirQ be selected based
on weight and the amount of opening the mouth of pa-
tients. In addition, it should be confirmed based on the
physiological and anatomical specifications of the patient
(14). In two studies by Yamada et al. no significant differ-
ences were found between the AirQILA and LMAfastrach
groups in the success of tubing after three attempts in two
different positions of the patient’s head. Hence, after two
attempts in an unnatural head position, the success of tub-
ing in the AirQ-ILA group was less than the LMAfastrach
group (26, 27). The lack of consistency between some of our
results and other studies may be due to differences in phys-
iological and anatomical specifications of patients, posi-
tion of the patient during application of the airway instru-
ment and tracheal tube, size of the airway instrument and
tracheal tube, different factory products of the airway in-
strument and tracheal tube, or different methods of gen-
eral anesthesia.
In this study, no significant difference was found in
hemodynamic changes (i.e., SBP, DBP, MAP, and HR) be-
tween the LMAfastrach and AirQ-ILA groups after induction
and intubation. In a study by Malhotra et al. (17) which
found similar results to this one, hemodynamic changes
were not significantly different between the LMAfastrach
and AirQ-ILA groups. Furthermore, in a study by Shamaa et
al. which found similar results to this study, no difference
was found in HR after induction and intubation between
the LMA fastrach and AirQ-ILA groups. Additionally, no sig-
nificant difference was found in terms of MAP after induc-
tion and intubation between the groups, although the in-
crease in MAP after intubation was higher in the AirQ-ILA
group (18). Consistent with the study here, Abdel-Halim
et al. showed no significant differences in MAP and HR
one minute after device placement and intubation in the
LMAfastrach and AirQ-ILA groups. However, unlike this
study, after applying the tracheal tube, there was a differ-
ence between the HR of the two groups (21). Badawi et al.
(20) in a study consistent with this one, noticed that before
and after applying instrument there was a difference be-
tween the hemodynamic changes (e.g., HR and blood pres-
sure) in patients undergoing elective surgery between the
LMAfastrach and AirQ-IL groups.
Based on the present results, there was no meaningful
difference between the indicating effects, including sore
throat, harshness of voice, and bleeding of patients un-
der elective surgery between the LMAfastrach and AirQ-IL
groups. The study of Malhotra et al. (17) which showed sim-
ilar results to this one, reached the same conclusion as did
this study. In the other study done by Shamaa et al. (18) no
difference was observed in complications, including sore
throat, voice disorder, and bleeding, between the LMAfas-
trach and AirQ-IL groups. In the study of Garzon Sanchez
et al. (19) which showed results consistent with our study,
they stated that both the LMAfastrach and AirQ-IL meth-
ods have the same rate of side effects, including sore throat
and harshness of voice. The study of Abdel-Halim et al.
(21) which showed results consistent with our study, con-
cluded that there was no difference between indicating ef-
fects, including a sore throat, in patients under surgery be-
tween the LMAfastrach and AirQIL groups. Badawi et al.
(20) who showed consistent results with this study, indi-
cated no difference in sore throat, harshness of voice, and
bleeding between the LMAfastrach and AirQ-IL groups. In
the study of Neoh and Choy (22) which showed results con-
sistent with those of this study, they noticed that there was
no significant difference between the indicating effects, in-
cluding sore throat, harshness of voice, and bleeding in pa-
tients under elective surgery between the LMAfastrach and
AirQ-IL groups. Karim and Swanson (13) which showed re-
sults similar to those of the study here, understood that
there was no difference between the indicating effects, in-
cluding sore throat, harshness of voice, and bleeding of pa-
tients undergoing elective surgery in the LMAfastrach and
AirQ-IL groups. Similarly, in the study by Sastre et al. (24)
the side effects (sore throat and harshness of voice) were
similar in the LMAfastrach and AirQ-IL groups.
As it is shown in Table 9, we also compared the suc-
cess rate of tube insertion through the device in patients
with high Mallampati class in the study groups, which was
not performed in previous available studies. Although the
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number of patients on whom tube insertion through the
device was larger in LMAfastrch group than those in AirQ-
Ila group, the difference was not statistically significant. To
reach a valuable conclusion in this matter, larger number
of patients might be needed.
4.1. Conclusion
The present study showed no significant difference be-
tween the LMA fastrach and AirQ-ILA groups in terms of
success in airway instrument application and tracheal in-
tubation, number of attempts to successfully place the air-
way instrument and intubate the trachea, hemodynamic
changes, and side effects. However, the time needed to
properly place the airway device and intubate the tra-
chea was longer in the AirQ-ILA method than LMAfastrach
method.
4.2. Further Suggestions
Since small sizes of the AirQ devices are available, per-
forming future studies to evaluate the efficiency of this
instrument in the intubation of children is needed. Fur-
thermore, as one of the indications of application of these
supraglotic airways is difficult airway management; fur-
ther studies on patients with high Mallampati class and in
larger number of patients are suggested.
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